Infection model | Canonical pathway | B-H p- value | mola/molb |
---|---|---|---|
Mouse | Acute Phase Response Signaling | 2.34E-10 | 28/177 |
 | LXR/RXR Activation | 2.34E-10 | 26/136 |
 | Atherosclerosis Signaling | 3.47E-09 | 22/129 |
 | Hepatic Fibrosis / Hepatic Stellate Cell Activation | 6.31E-07 | 21/147 |
 | IL-12 Signaling and Production in Macrophages | 1.12E-06 | 20/155 |
 | Complement System | 4.07E-06 | 10/35 |
 | Type I Diabetes Mellitus Signaling | 5.50E-06 | 17/121 |
 | Nitrogen Metabolism | 8.51E-05 | 9/120 |
 | Clathrin-mediated Endocytosis Signaling | 1.30E-04 | 20/195 |
 | Dendritic Cell Maturation | 1.70E-04 | 18/185 |
Macaque | VDR/RXR Activation | 3.63E-03 | 13/81 |
 | Hematopoiesis from Pluripotent Stem Cells | 5.25E-03 | 10/64 |
 | Communication between Innate and Adaptive Immune Cells | 2.75E-02 | 12/109 |
 | Type I Diabetes Mellitus Signaling | 3.16E-02 | 13/121 |
 | Altered T Cell and B Cell Signaling in Rheumatoid Arthritis | 3.80E-02 | 11/92 |
 | Gα12/13 Signaling | 3.80E-02 | 13/127 |
 | Neuroprotective Role of THOP1 in Alzheimer's Disease | 3.80E-02 | 7/54 |
 | Hematopoiesis from Multipotent Stem Cells | 3.80E-02 | 4/12 |
 | Primary Immunodeficiency Signaling | 3.80E-02 | 8/63 |
 | Pyrimidine Metabolism | 3.80E-02 | 14/215 |
Swine | LXR/RXR Activation | 1.15E-07 | 20/136 |
 | Nitrogen Metabolism | 9.33E-04 | 8/120 |
 | Antigen Presentation Pathway | 9.33E-04 | 8/40 |
 | Communication between Innate and Adaptive Immune Cells | 9.33E-04 | 12/109 |
 | Hepatic Fibrosis / Hepatic Stellate Cell Activation | 9.33E-04 | 15/147 |
 | Type I Diabetes Mellitus Signaling | 9.33E-04 | 13/121 |
 | Primary Immunodeficiency Signaling | 9.33E-04 | 9/63 |
 | Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses | 9.33E-04 | 12/106 |
 | TREM1 Signaling | 9.33E-04 | 9/66 |
 | Atherosclerosis Signaling | 1.12E-03 | 13/129 |